Common Fungi. Catherine Diamond MD MPH

Size: px
Start display at page:

Download "Common Fungi. Catherine Diamond MD MPH"

Transcription

1 Common Fungi Catherine Diamond MD MPH

2

3 Birth Month and Day & Last Four Digits of Your Cell Phone # BEFORE: AFTER:

4 Clinically Common Fungi Yeast Mold Dermatophytes Candida Coccidioides Cryptococcus Histoplasma Blastomycosis Aspergillus Mucor Epidermophyton Trichophyton Microsporum

5 Fungus among Us: A Gross Simplification Serious Immunocompromised, hospitalized e.g. cryptococcal meningitis, pulmonary aspergillus Seen mainly by infectious disease specialists, oncologists, hospitalists, intensivists Increasing Annoying Community dwellers e.g. onychomycosis, vaginal candidiasis Seen mainly by primary care MDs (FP, IM, peds, gyn), dermatologists, podiatrists Always with us

6

7

8 Case One A 32 year old man was diagnosed with AIDS two years ago but did not return for care. He complains of a headache and blurred vision.

9 C. neoformans found in soil samples from around the world in areas frequented by birds, especially pigeons and chickens, and in association with rotting vegetation

10 Cryptococcus predominantly presents as meningitis in patients with AIDS, organ transplant or chronic corticosteroids Pulmonary and skin disease also occur Immunocompetent disease rare Presentation

11 Diagnosis Serum & CSF cryptococcal antigen CSF fungal culture CSF protein, glucose, cell count

12 Treatment Induction: amphotericin & flucytosine Suppression: oral fluconazole

13 Complications Increased intracranial pressure which can result in blindness Must check opening pressure! Abnormal defined as >20 cm H20 Immune reconstitution syndrome (IRIS) ART started 2-10 weeks after antifungal Rx initiated

14 Take Home In AIDS or transplant patient with meningitis, think cryptococcus Check CSF cryptococci antigen, fungal culture & opening pressure Treat cryptococcus with induction amphotericin & flucytosine then suppression fluconazole

15 Case Two A 42 year old woman with ALL received chemotherapy and become neutropenic. She developed a fever. Chest X-ray shows a right upper lobe cavity.

16

17

18

19 Presentation Invasive aspergillosis Pulmonary Rhinocerebral (r/o Mucor) Allergic bronchopulmonary aspergillosis(abpa)/sinusitis Chronic pulmonary aspergillosis Skin disease much less common

20 Diagnosis Culture Galactomannan serum & BAL Galactomannan is a polysaccharide that is a major constituent of Aspergillus cell walls May also be positive with fusarium, histoplama

21 Treatment Voriconazole Amphotericin Isavuconazole

22 Mucor vs Aspergillus Both aspergillus & mucor cause rhino orbital cerebral disease in immunocompromised (hematologic malignancies, neutropenic, corticosteroids) Mucor had a predilection for DM Voriconazole will not treat mucor; use amphotericin

23

24 Mucor Microbiology Mucor hyphae are broader with irregular branching & rare septation in comparison to aspergillus Rhizopus is a species in the order mucorales Mucor may not grow in culture BD glucan not positive in mucor

25 Take Home In immunocompromised patient with lung cavity or sinus disease, think aspergillus (or mucor) Check pathology, fungal culture and galactomannan serum and BAL Treat aspergillus with voriconazole and mucor with amphotericin

26 Case Four A 54 year old male truck driver with no PMH is admitted to the intensive care unit with severe bilateral pneumonia requiring intubation. Sputum cultures and legionella urinary antigen are negative and he is not responding to intravenous ceftriaxone and azithromycin

27 Coccidomycosis Spherule with Endospores

28

29

30 Presentation Primary Valley Fever (ranges from asymptomatic to severe and may be immunocompetent or immunocompromised) Pneumonia Skin Erythema nododosum Erythema multiforme Pulmonary sequelae Cavities Nodules Disseminated Bone & joint Meningitis Skin

31

32 Diagnosis Serology Enzyme Immunoassay screen Confirm and titer with complement fixation or immunodiffusion In contrast to histoplasma, antigen not used (insensitive) Characteristic pathology Cultures may be positive but are a hazard to lab personnel

33 Treatment Fluconazole Itraconazole for bone/joint Amphotericin

34 Case Five A 47 year old woman with poorly controlled inflammatory bowel disease is transferred from the colorectal service on piperacillin/tazobactam and TPN because of fever and hypotension.

35 Presentation Fungemia Line infection Hepatosplenic candidiasis Endophthalmitis Oral thrush Esophagitis Vaginitis

36 Diagnosis Fungal blood culture (may grow in routine culture as well) KOH stain Visual

37

38

39 Kondo T, Terada K. N Engl J Med 2017;376: Candida Esophagitis

40

41

42 Treatment None (funguria) Skin Nystatin or clotrimazole Thrush Fluconazole Nystatin or clotrimazole Esophagitis Fluconazole Candidemia Micafungin initially Fluconazole (krusei resistant, glabrata dose dependent) Amphotericin (lusitaniae resistant)

43 Take Home Use micafungin for empiric therapy of candidemia

44 Conclusions Mild fungal infections (tinea, onochomycosis) occur in immunocompromised and immunocompetent but mostly harmless Serious fungal infections (cryptococcus, aspergillus, mucor) tend to occur in immunocompromised hosts Endemic fungi (cocci, histo, blasto) and candida occur in immunocompromised and immunocompetent and vary in severity

45 Birth Month and Day & Last Four Digits of Your Cell Phone # BEFORE: AFTER:

Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson

Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson Fungal infection in the immunocompromised patient Dr Kirsty Dodgson Aims Discuss different types of fungi Overview of types of clinical infections Clinical Manifestations Fungus Includes Moulds Aspergillus

More information

Management of fungal infection

Management of fungal infection Management of fungal infection HKDU symposium 17 th May 2015 Speaker: Dr. Thomas Chan MBBS (Hons), MRCP, FHKCP, FHKAM Synopsis Infection caused by fungus mycoses Skin infection by fungus is common in general

More information

Case Studies in Fungal Infections and Antifungal Therapy

Case Studies in Fungal Infections and Antifungal Therapy Case Studies in Fungal Infections and Antifungal Therapy Wayne L. Gold MD, FRCPC Annual Meeting of the Canadian Society of Internal Medicine November 4, 2017 Disclosures No financial disclosures or industry

More information

Fungal update. Liise-anne Pirofski, M.D. Albert Einstein College of Medicine

Fungal update. Liise-anne Pirofski, M.D. Albert Einstein College of Medicine Liise-anne Pirofski, M.D. Albert Einstein College of Medicine Fungal update http://clicks.robertgenn.com/miss-potter.php http://letterfromhere.blogspot.com/2007/06/beatrix-potters-jog-trot-through.html

More information

ECMM Excellence Centers Quality Audit

ECMM Excellence Centers Quality Audit ECMM Excellence Centers Quality Audit Person in charge: Department: Head of Department: Laboratory is accredited according to ISO 15189 (Medical Laboratories Requirements for quality and competence) Inspected

More information

Fungal biology. Fungal Infections. Fungal cell structure. Pathogenesis

Fungal biology. Fungal Infections. Fungal cell structure. Pathogenesis Fungal Infections Once exotic and rare; now increasingly common Fungi are not virulent But they are good at taking advantage Opportunistic in many senses Fungal biology Eukaryotic (organized nucleus and

More information

Fungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile

Fungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile Fungal Infections Once exotic and rare; now increasingly common Fungi are not virulent But they are good at taking advantage Opportunistic in many senses Fungal biology Eukaryotic (organized nucleus and

More information

Use of Antifungals in the Year 2008

Use of Antifungals in the Year 2008 Use of Antifungals in the Year 2008 Jose G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School of Medicine Diagnosis

More information

Fungal Infection Post-Infusion Data

Fungal Infection Post-Infusion Data Fungal Infection Post-Infusion Data Registry Use Only Sequence Number: Date Received: CIBMTR Center Number: Event date: / / Visit: 100 day 6 months 1 year 2 years >2 years. Specify: CIBMTR Form 2146 revision

More information

Use of Antifungal Drugs in the Year 2006"

Use of Antifungal Drugs in the Year 2006 Use of Antifungal Drugs in the Year 2006" Jose G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School of Medicine

More information

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS Paul D. Holtom, MD Associate Professor of Medicine and Orthopaedics USC Keck School of Medicine Numbers of Cases of Sepsis in the United States, According

More information

Fungal Infection Pre-Infusion Data

Fungal Infection Pre-Infusion Data Fungal Infection Pre-Infusion Data Registry Use Only Sequence Number: Date Received: CIBMTR Center Number: Event date: / / CIBMTR Form 2046 revision 5 (page 1 of 5). Last Updated May, 2018. Infection Episode

More information

Antifungal drugs Dr. Raz Muhammed

Antifungal drugs Dr. Raz Muhammed Antifungal drugs 13. 12. 2018 Dr. Raz Muhammed 2. Flucytosine (5-FC) Is fungistatic Is a synthetic pyrimidine antimetabolite Is often used in combination with amphotericin B in the treatment of systemic

More information

Fungal Infections. Fungal Infections

Fungal Infections. Fungal Infections Fungal Infection in the Immune Competent Host Steven L. Primack, MD Fungal Infection in the Immune Competent Host Steven L. Primack, MD Department of Radiology Oregon Health & Science University Fungal

More information

Condition First line Alternative Comments Candidemia Nonneutropenic adults

Condition First line Alternative Comments Candidemia Nonneutropenic adults Recommendations for the treatment of candidiasis. Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America. Condition First line Alternative

More information

Introduction. Study of fungi called mycology.

Introduction. Study of fungi called mycology. Fungi Introduction Study of fungi called mycology. Some fungi are beneficial: ex a) Important in production of some foods, ex: cheeses, bread. b) Important in production of some antibiotics, ex: penicillin

More information

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement Rheem Totah, Office H172M, Ph 206-543-9481 rtotah@uw.edu Office hours MWF 11:30 12:20 or by arrangement Date/Time Topic Readings Mon March 26 Antifungal agents Foye s Chapter 40 Wed March 28 Antifungal

More information

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell Antifungal Drugs Fungal infections (Mycoses) Often chronic in nature. Mycotic infections may be superficial and involve only the skin (cutaneous mycoses extending into the epidermis) Others may penetrate

More information

Pulmonary Infections: Fungus. Part I: Background Information and Dimorphic Fungus. Part II: Opportunistic Yeast and Molds

Pulmonary Infections: Fungus. Part I: Background Information and Dimorphic Fungus. Part II: Opportunistic Yeast and Molds Pulmonary Infections: Fungus Part I: Background Information and Dimorphic Fungus Part II: Opportunistic Yeast and Molds Howard J. Sachs, MD www.12daysinmarch.com Classification: Unicellular Budding Yeast,

More information

Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases. Y.L. Kwong Department of Medicine University of Hong Kong

Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases. Y.L. Kwong Department of Medicine University of Hong Kong Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases Y.L. Kwong Department of Medicine University of Hong Kong Pathogenic yeast Candida Cryptococcus Trichosporon Pathogenic

More information

Mycology Reference Centre, Leeds Information for Service Users 2017

Mycology Reference Centre, Leeds Information for Service Users 2017 The Leeds Teaching Hospitals NHS Trust NHS Mycology Reference Centre, Leeds Information for Service Users 2017 Contents Contents...1 The Mycology Reference Centre...1 Request Forms... 1 Specimen Transportation...

More information

Fungal Meningitis. Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse Bern

Fungal Meningitis. Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse Bern Fungal Meningitis Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse 51 3010 Bern Death due to infectious diseases in sub-saharan Africa Park BJ. Et al AIDS 2009;23:525

More information

Antifungal therapies differences in agents

Antifungal therapies differences in agents Antifungal therapies differences in agents The basic Fungi are eukaryotes Eukaryote = an organism whose cells contain complex structures enclosed within membrane. Most Common Fungal Pathogens Dermatophytes

More information

ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS

ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS COMMERCIAL RELATIONS DISCLOSURE 2500 9000 15000 Astellas Gilead Sciences Pfizer Inc Expert advice Speaker s bureau Speaker s bureau OUTLINE OF THE PRESENTATION

More information

Fungal Infections: Reporting. Marcie Tomblyn, MD, MS Associate Member, Moffitt Cancer Center

Fungal Infections: Reporting. Marcie Tomblyn, MD, MS Associate Member, Moffitt Cancer Center Fungal Infections: Management and Reporting Marcie Tomblyn, MD, MS Associate Member, Moffitt Cancer Center February 25, 2010 Objectives Review common fungal infections in HCT patients Review current available

More information

Case 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1

Case 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1 TB or Not TB? Case 1 Gisela Schecter, M.D., M.P.H. California Department of Public Health Background 26 year old African American male Born and raised in Bay Area of California Convicted of cocaine trafficking

More information

PAGL Inclusion Approved at January 2017 PGC

PAGL Inclusion Approved at January 2017 PGC Guideline for the prophylaxis and treatment of fungal infections in Haematology patients 1. Introduction PAGL Inclusion Approved at January 2017 PGC Haematology, CHUGGS June 2016 This guideline sets out

More information

HAEMATOLOGY ANTIFUNGAL POLICY

HAEMATOLOGY ANTIFUNGAL POLICY HAEMATOLOGY ANTIFUNGAL POLICY PROPHYLAXIS Primary Prophylaxis Patient Group Patients receiving intensive remissioninduction chemotherapy for Acute Leukaemia (excluding patients receiving vinca alkaloids)

More information

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy:

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy: MYCOLOGY Mycology I Fungi Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy: Morphology Spore formation FFungi Yeast Mold Yeastlike

More information

Antifungal Update 2/22/12. Which is the most appropriate initial empirical therapy in a candidemic patient?

Antifungal Update 2/22/12. Which is the most appropriate initial empirical therapy in a candidemic patient? Antifungal Update B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy School of Pharmacy University of California San Francisco 3/3 blood cultures are positive for an unidentified

More information

2046: Fungal Infection Pre-Infusion Data

2046: Fungal Infection Pre-Infusion Data 2046: Fungal Infection Pre-Infusion Data Fungal infections are significant opportunistic infections affecting transplant patients. Because these infections are quite serious, it is important to collect

More information

Case. Fungal infections for the community provider. Case. Case. April 25, 2014 Peter V. Chin-Hong M.D. Infectious Diseases UCSF UCSF

Case. Fungal infections for the community provider. Case. Case. April 25, 2014 Peter V. Chin-Hong M.D. Infectious Diseases UCSF UCSF Case Fungal infections for the community provider April 25, 2014 Peter V. Chin-Hong M.D. Infectious Diseases UCSF peter.chin-hong@ucsf.edu UCSF A 38-year-old African-American female financial analyst is

More information

Fungal Infections. Alessandro Diana November 22th 2007

Fungal Infections. Alessandro Diana November 22th 2007 Fungal Infections Alessandro Diana November 22th 2007 alessandro.diana@ne.ch Topics Aspergillosis Candidiasis Cryptococcosis Histoplasmosis Coccidioidomycosis Blastomyocosis Sporotrichosis Pneumocystis

More information

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens Cryptococcus neoformans Candida albicans Aspergillus species Pneumocystis carinii 1 Dermatophytes Named for derma skin Cause

More information

Antifungal Update. Candida: In Vitro Antifungal Susceptibility Testing

Antifungal Update. Candida: In Vitro Antifungal Susceptibility Testing Antifungal Update B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy School of Pharmacy University of California San Francisco The patient spikes a new fever and 3/3 blood

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Voriconazole Effective Date... 3/15/2018 Next Review Date... 3/15/2019 Coverage Policy Number... 4004 Table of Contents Coverage Policy... 1 General Background...

More information

Neutropenic Fever. CID 2011; 52 (4):e56-e93

Neutropenic Fever.  CID 2011; 52 (4):e56-e93 Neutropenic Fever www.idsociety.org CID 2011; 52 (4):e56-e93 Definitions Fever: Single oral temperature of 101 F (38.3 C) Temperature 100.4 F (38.0 C) over 1 hour Neutropenia: ANC < 500 cells/mm 3 Expected

More information

How to make a fast diagnosis

How to make a fast diagnosis How to make a fast diagnosis 8 th Advances Against Aspergillosis 1 3 February 2018 Lisbon, Portugal Cornelia Lass-Flörl Division of Hygiene and Medical Microbiology Innsbruck Medical University Division

More information

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia Fungal infections in ICU Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia Epidemiology of invasive fungal infections - US +300% Martin GS, et al. N Engl J Med 2003;348:1546-1554

More information

TOWARDS PRE-EMPTIVE? TRADITIONAL DIAGNOSIS. GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% β-d-glucan Neg Predict Value 100% PCR

TOWARDS PRE-EMPTIVE? TRADITIONAL DIAGNOSIS. GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% β-d-glucan Neg Predict Value 100% PCR TOWARDS PRE-EMPTIVE? GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% TRADITIONAL DIAGNOSIS β-d-glucan Neg Predict Value 100% PCR diagnostics FUNGAL BURDEN FIRST TEST POSITIVE FOR ASPERGILLOSIS

More information

Improving Clinical Outcomes in Fungal Infection Control and Management

Improving Clinical Outcomes in Fungal Infection Control and Management Improving Clinical Outcomes in Fungal Infection Control and Management DISCLAIMER The information within this CME/CE activity is for continuing education purposes only, and is not intended to substitute

More information

Ali Alabbadi. Sarah Jaar ... Nader

Ali Alabbadi. Sarah Jaar ... Nader 24 Ali Alabbadi Sarah Jaar... Nader Intro to Mycology *underlined text was explained in the lecture but is not found in the slides -mycology: the study of the mycoses of man (fungal infections) -less than

More information

General History. 林陳 珠 Female 69 years old 住院期間 : ~ Chief Complaint : sudden loss of conscious 5 minutes in the morning.

General History. 林陳 珠 Female 69 years old 住院期間 : ~ Chief Complaint : sudden loss of conscious 5 minutes in the morning. General History 林陳 珠 Female 69 years old 住院期間 : 93.5.8~93.5.15 Chief Complaint : sudden loss of conscious for 2-52 5 minutes in the morning. General History DM under regular medical control for 10 years.

More information

Antifungal Update 2/24/11. Which is the most appropriate initial empirical therapy in a candidemic patient?

Antifungal Update 2/24/11. Which is the most appropriate initial empirical therapy in a candidemic patient? Antifungal Update B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy School of Pharmacy University of California San Francisco The patient spikes a new fever and 3/3 blood

More information

Voriconazole October 2015 Risk Management Plan. Voriconazole

Voriconazole October 2015 Risk Management Plan. Voriconazole Voriconazole October 2015 VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Invasive aspergillosis (IA) is the most devastating of Aspergillus related diseases, targeting severely

More information

Invasive Fungal Infections in Solid Organ Transplant Recipients

Invasive Fungal Infections in Solid Organ Transplant Recipients Outlines Epidemiology Candidiasis Aspergillosis Invasive Fungal Infections in Solid Organ Transplant Recipients Hsin-Yun Sun, M.D. Division of Infectious Diseases Department of Internal Medicine National

More information

Current Options in Antifungal Pharmacotherapy

Current Options in Antifungal Pharmacotherapy Current Options in Antifungal Pharmacotherapy John Mohr, Pharm.D., Melissa Johnson, Pharm.D., Travis Cooper, Pharm.D., James S. Lewis, II, Pharm.D., and Luis Ostrosky-Zeichner, M.D. Infections caused by

More information

CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS. Dr AMIT RAODEO DM SEMINAR

CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS. Dr AMIT RAODEO DM SEMINAR CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS Dr AMIT RAODEO DM SEMINAR Introduction The incidence of invasive fungal infections in critically ill intensive

More information

North American Endemic Fungi

North American Endemic Fungi North American Endemic Fungi Boni Elizabeth Elewski, MD Chair Department of Dermatology University of Alabama at Birmingham James Elder Professor of Graduate Medical Education DISCLOSURE OF FINANCIAL RELATIONSHIPS

More information

number Done by Corrected by Doctor

number Done by Corrected by Doctor number 19 Done by عمرسامي Corrected by حسام أبو عوض Doctor حامد الزعبي Fungal infections - Fungal infections are infections caused by fungi, a type of microorganisms. Which sites are mostly affected? -

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our

More information

Dr Kaniz Fatema. FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital

Dr Kaniz Fatema. FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital Dr Kaniz Fatema FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital 65-years old lady HTN (15 yrs) Adult Still s Disease (2 mon)

More information

Antifungals and current treatment guidelines in pediatrics and neonatology

Antifungals and current treatment guidelines in pediatrics and neonatology Dragana Janic Antifungals and current treatment guidelines in pediatrics and neonatology Dragana Janic. University Children`s Hospital, Belgrade, Serbia 10/10/17 Hotel Crowne Plaza, Belgrade, Serbia; www.dtfd.org

More information

PROGRESSI NELLA TERAPIA ANTIFUNGINA. A tribute to Piero Martino

PROGRESSI NELLA TERAPIA ANTIFUNGINA. A tribute to Piero Martino PROGRESSI NELLA TERAPIA ANTIFUNGINA A tribute to Piero Martino 1946-2007 ITALIAN ICONS IERI, OGGI, E DOMANI IERI, OGGI, E DOMANI IERI, OGGI, E DOMANI 1961 CAUSES OF DEATH IN PATIENTS WITH MALIGNANCIES

More information

Fungal Infections in Neutropenic Hematological Disorders

Fungal Infections in Neutropenic Hematological Disorders Fungal Infections in Neutropenic Hematological Disorders 23 Dr Farah Jijina 24 Fungal Infections in Neutropenic Hematological Disorders 25 Dr Farah Jijina 26 Fungal Infections in Neutropenic Hematological

More information

Antifungal Agents - Cresemba (isavuconazonium), Vfend. Prior Authorization Program Summary

Antifungal Agents - Cresemba (isavuconazonium), Vfend. Prior Authorization Program Summary Antifungal Agents - Cresemba (isavuconazonium), Noxafil (posaconazole), Vfend (voriconazole) Prior Authorization Program Summary FDA APPROVED INDICATIONS DOSAGE 1,2,14 Drug FDA Indication(s) Dosing Cresemba

More information

Approach to Fungal Infections

Approach to Fungal Infections Approach to Fungal Infections Michelle A. Barron, M.D. Professor of Medicine Division of Infectious Diseases University of Colorado Denver Disclosures Research Investigation with Astellas Pharma, US I

More information

Cryptococcal Meningitis

Cryptococcal Meningitis Cryptococcal Meningitis Dr N Thumbiran Infectious Diseases Department UKZN Index patient 27 year old female Presented to King Edward Hospital on 17/07/2005 with: Severe headaches Vomiting Photophobia X

More information

Introduction Medical Mycology. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan

Introduction Medical Mycology. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan Introduction Medical Mycology Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan General Fungi-1 Medical Mycology deals with fungi cause human diseases directly (mycoses, allergies) or indirectly

More information

Epidemiology and ecology of fungal diseases

Epidemiology and ecology of fungal diseases Epidemiology and ecology of fungal diseases Healthcare Focus on: - individual - diagnosis - treatment Public Health Focus on: - population - prevention The nature of fungi Kingdom Fungi (lat. fungus, -i)

More information

About the Editor Gerri S. Hall, Ph.D.

About the Editor Gerri S. Hall, Ph.D. About the Editor Gerri S. Hall, Ph.D. Dr. Hall s professional career has been focused on clinical microbiology: direct clinical activities of various areas such as bacteriology, mycobacteria, STD testing,

More information

Mycobacteria and fungal infections of the respiratory tract

Mycobacteria and fungal infections of the respiratory tract Before you start: You must read the slides! The Dr. did not bother to explain them all Mycobacteria and fungal infections of the respiratory tract - TB is a global problem that the WHO is trying to combat.

More information

Aspergillus species. The clinical spectrum of pulmonary aspergillosis

Aspergillus species. The clinical spectrum of pulmonary aspergillosis Pentalfa 3 maart 2016 The clinical spectrum of pulmonary aspergillosis Pascal Van Bleyenbergh, Pneumologie UZ Leuven Aspergillus species First described in 1729 * >250 species * ubiquitous Inhalation of

More information

Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance 13

Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance 13 Fungal Infections Preface: Fungal Infections Luis Ostrosky-Zeichner and Jack D. Sobel xiii The Global Burden of Fungal Diseases 1 Snigdha Vallabhaneni, Rajal K. Mody, Tiffany Walker, and Tom Chiller Fungal

More information

ESCMID Online Lecture Library. by author. CASE PRESENTATION ECCMID clinical grand round May Anat Stern, MD Rambam medical center Haifa, Israel

ESCMID Online Lecture Library. by author. CASE PRESENTATION ECCMID clinical grand round May Anat Stern, MD Rambam medical center Haifa, Israel CASE PRESENTATION ECCMID clinical grand round May 2014 Anat Stern, MD Rambam medical center Haifa, Israel An 18 years old Female, from Ukraine, diagnosed with acute lymphoblastic leukemia (ALL) in 2003.

More information

Fungal infections and critically ill adults

Fungal infections and critically ill adults Martin Beed FRCA FFICM DM Richard Sherman MRCP FRCA FFICM Stephen Holden MSc FRCPath 1A02,2C03 Key points The incidence of fungal diseases in critically ill patients is thought to be increasing, most commonly

More information

Current and Emerging Azole Antifungal Agents

Current and Emerging Azole Antifungal Agents CLINICAL MICROBIOLOGY REVIEWS, Jan. 1999, p. 40 79 Vol. 12, No. 1 0893-8512/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Current and Emerging Azole Antifungal Agents

More information

New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance

New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance For reprint orders, please contact reprints@expert-reviews.com New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance Expert Rev. Anti Infect. Ther. 7(8), 981 998

More information

Management Strategies For Invasive Mycoses: An MD Anderson Perspective

Management Strategies For Invasive Mycoses: An MD Anderson Perspective Management Strategies For Invasive Mycoses: An MD Anderson Perspective Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA Professor of Medicine Director of Mycology Research Program M. D. Anderson Cancer

More information

8/2/10. Sanaz Jalali, Jennifer Demler, Jeremy King. Histoplasmosis is an intracellular mycotic infection of the reticuloendothelial system.

8/2/10. Sanaz Jalali, Jennifer Demler, Jeremy King. Histoplasmosis is an intracellular mycotic infection of the reticuloendothelial system. Histoplasmosis is an intracellular mycotic infection of the reticuloendothelial system. Type of chronic respiratory infection http://www.eregimens.com/regimens/antifungal%20general.htm Sanaz Jalali, Jennifer

More information

Antifungal Resistance in Asia: Mechanisms, Epidemiology, and Consequences

Antifungal Resistance in Asia: Mechanisms, Epidemiology, and Consequences 5th MMTN Conference 5-6 November 2016 Bangkok, Thailand 10:20-10:45, 6 Nov, 2016 Antifungal Resistance in Asia: Mechanisms, Epidemiology, and Consequences Yee-Chun Chen, M.D., PhD. Department of Medicine,

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: itraconazole (Sporanox) Reference Number: HIM.PA.36 Effective Date: 05/16 Last Review Date: Line of Business: Health Insurance Marketplace Coding Implications Revision Log See Important

More information

Fungal and Viral Infections

Fungal and Viral Infections CHAPTER 89 Fungal and Viral Infections Palash Samanta, Ghady Haidar, Minh Ly Nguyen, Cornelius J. Clancy, and M. Hong Nguyen FUNGAL INFECTIONS Fungal Pathogens Medically relevant fungi are classically

More information

Coccidioidomycosis, aka Valley Fever

Coccidioidomycosis, aka Valley Fever Coccidioidomycosis, aka Valley Fever Presented to the California Partnership for the San Joaquin Valley June 15, 2018 Karen Haught, MD, MPH Public Health Officer Tulare County Public Health Coccidioidomycosis

More information

Invasive Pulmonary Aspergillosis in

Invasive Pulmonary Aspergillosis in Infection & Sepsis Symposium Porto, April 1-3, 2009 Invasive Pulmonary Aspergillosis in Non-Immunocompromised Patients Stijn BLOT, PhD General Internal Medicine & Infectious Diseases Ghent University Hospital,

More information

California digging. Task 1 Interpret the chest radiograph. L. Hendriks

California digging. Task 1 Interpret the chest radiograph. L. Hendriks Case history An18-yr-old male presented at the emergency department with a 4-week history of fever, coughing and dyspnoea. Symptoms presented on a holiday in California (USA) searching the desert for fossils.

More information

1. Pre-emptive therapy. colonization, colonization, pre-emptive therapy. , ICU colonization. colonization. 2, C. albicans

1. Pre-emptive therapy. colonization, colonization, pre-emptive therapy. , ICU colonization. colonization. 2, C. albicans Jpn. J. Med. Mycol. Vol. 45, 217 221, 2004 ISSN 0916 4804,.,, colonization, pre-emptive therapy. 2, non-albicans Candida., fluconazole.,. Key words: postoperative infection, non-albicans Candida, pre-emptive

More information

9/7/2018. Faculty. Overcoming Challenges in the Management of Invasive Fungal Infections. Learning Objectives. Faculty Disclosure

9/7/2018. Faculty. Overcoming Challenges in the Management of Invasive Fungal Infections. Learning Objectives. Faculty Disclosure Faculty Overcoming Challenges in the Management of Invasive Fungal James S. Lewis II, PharmD, FIDSA ID Clinical Pharmacy Coordinator Oregon Health and Science University Departments of Pharmacy and Infectious

More information

ANTIMYCOTIC DRUGS Modes of Action

ANTIMYCOTIC DRUGS Modes of Action ANTIMYCOTIC DRUGS Modes of Action Prapasarakul Nuvee, D.V.M., Ph.D. Department of Veterinary Microbiology, Faculty of Veterinary Science, Chulalongkorn University 1 What drugs act as antifungal agents?

More information

Dr Hamed Alzoubi. Fungal infections

Dr Hamed Alzoubi. Fungal infections Dr Hamed Alzoubi Fungal infections Skin & subcutaneous Mycoses 1-Superficial mycoses such as 2-Cutaneous mycoses such as 3-Subcutaneous mycoses Tinea versicolor or Pityriasis versicolor Ring worm or Tinea

More information

Antifungal Agents. Polyenes Azoles Allyl and Benzyl Amines Other antifungals

Antifungal Agents. Polyenes Azoles Allyl and Benzyl Amines Other antifungals OPTO 6434 General Pharmacology Antifungal Agents Dr. Alison McDermott Room 254 HBSB, Phone 713-743 1974 Email amcdermott@optometry.uh.edu Fall 2015 Reading: Chapter 50 Brody s Human Pharmacology by Wecker

More information

Diagnostic Procedures for Pulmonary Infiltrates in the Compromised Host

Diagnostic Procedures for Pulmonary Infiltrates in the Compromised Host Diagnostic Procedures for Pulmonary Infiltrates in the Compromised Host Michael Douvas, MD Heme/Onc Gerald Donowitz, MD - ID Eric Davis, MD - Pulmonary Disclosure Drs. Davis, Donowitz, and Douvas do not

More information

Invasive Fungal Infections

Invasive Fungal Infections C H A P T E R 18 Invasive Fungal Infections Ayesha J Sunavala, Rajeev Soman The four most important fungi producing invasive fungal infections (candida, cryptococcus, aspergillus and mucor) are commonly

More information

Treatment of Coccidioidomycosis-associated Eosinophilic Pneumonia with Corticosteroids

Treatment of Coccidioidomycosis-associated Eosinophilic Pneumonia with Corticosteroids Treatment of Coccidioidomycosis-associated Eosinophilic Pneumonia with Corticosteroids Joshua Malo, MD Yuval Raz, MD Linda Snyder, MD Kenneth Knox, MD University of Arizona Medical Center Department of

More information

The sensitivity of fungal microorganisms to fluconazole is as follows:

The sensitivity of fungal microorganisms to fluconazole is as follows: FLUCAN Composition Each capsule contains Fluconazole 50, 100 or 150 mg Capsules Action Fluconazole is a triazole anti-fungal, which in sensitive fungi, inhibits cytochrome P450-dependent enzymes resulting

More information

(Notes on Anti-TB agents are included in the TB syllabus)

(Notes on Anti-TB agents are included in the TB syllabus) (Notes on Anti-TB agents are included in the TB syllabus) Antifungal Agents A. Zuger MD General background: 1. Fungi are eukaryotes, with more cellular similarities to human cells than to bacterial cells.

More information

Med Chem 401: Mycology (www.doctorfungus.org) Mycology

Med Chem 401: Mycology (www.doctorfungus.org) Mycology Med Chem 401: Mycology (www.doctorfungus.org) Mycology is the Study of Fungi (Monera, Protoctista, Fungi, Plantae, Animalia). Fungi are eukaryotic cells and as such contain nuclei, mitochondria, ER, golgi,

More information

Trends in Invasive Fungal Infection (IFI) in Haematology-Oncology Patients. Saturday, April 18, 2015 Charlottetown, P.E.I.

Trends in Invasive Fungal Infection (IFI) in Haematology-Oncology Patients. Saturday, April 18, 2015 Charlottetown, P.E.I. Trends in Invasive Fungal Infection (IFI) in Haematology-Oncology Patients Saturday, April 18, 2015 Charlottetown, P.E.I. Moderator & Speaker: Shariq Haider MD, FRCPC, FACP, CCST(UK), DTMH(UK) Professor

More information

Updated Guidelines for Management of Candidiasis. Vidya Sankar, DMD, MHS April 6, 2017

Updated Guidelines for Management of Candidiasis. Vidya Sankar, DMD, MHS April 6, 2017 Updated Guidelines for Management of Candidiasis Vidya Sankar, DMD, MHS April 6, 2017 Statement of Disclosure I have no actual or potential conflict of interest in relation to this presentation Outline

More information

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? Assoc. Prof. Dr. Serkan SENER Acibadem University Medical School Department of Emergency Medicine, Istanbul Acibadem Ankara Hospital,

More information

An Update in the Management of Candidiasis

An Update in the Management of Candidiasis An Update in the Management of Candidiasis Daniel B. Chastain, Pharm.D., AAHIVP Infectious Diseases Pharmacy Specialist Phoebe Putney Memorial Hospital Adjunct Clinical Assistant Professor UGA College

More information

Research priorities in medical mycology

Research priorities in medical mycology Research priorities in medical mycology David W. Denning National Aspergillosis Centre University Hospital of South Manchester The University of Manchester Agenda How many patients are there with serious

More information

Fungi GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA

Fungi GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Fungi Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA Chapter Editor Ziad A. Memish, MD, FRCPC, FACP Cover heading - Topic Outline Topic outline

More information

Title: Author: Speciality / Division: Directorate:

Title: Author: Speciality / Division: Directorate: Antifungal guidelines for CANDIDIASIS INFECTIONS (Adults) Proven infection: Targeted antifungal therapy should be prescribed for: o Positive cultures from a sterile site with clinical or radiological abnormality

More information

Antifungals in Invasive Fungal Infections: Antifungals in neutropenic patients

Antifungals in Invasive Fungal Infections: Antifungals in neutropenic patients BVIKM-SBIMC La Hulpe, 6 November 2008 Antifungals in Invasive Fungal Infections: Antifungals in neutropenic patients Johan Maertens, MD Acute Leukemia and SCT Unit University Hospital Gasthuisberg Catholic

More information

number Done by Corrected by Doctor د.حامد الزعبي

number Done by Corrected by Doctor د.حامد الزعبي number Fungi#1 Done by نرجس الس ماك Corrected by مهدي الشعراوي Doctor د.حامد الزعبي Introduction to Mycology -Terms: -Medical Mycology: The study of mycosis and their etiological agents -Mycosis: Disease

More information

Lecture 7: Mycoses Caused by Dimorphic Fungi, Part I

Lecture 7: Mycoses Caused by Dimorphic Fungi, Part I BIOL 4849 Medical Mycology Summer 2006 Histoplasmosis Lecture 7: Mycoses Caused by Dimorphic Fungi, Part I u Most common endemic mycotic disease in the United States u Two different varieties (actually

More information

Introduction. Yeast candida, cryptococcus, trichosporon. Filamentous rhizopus, rhizomucor, mucor. Dimorphic Fungi bl t hi t l

Introduction. Yeast candida, cryptococcus, trichosporon. Filamentous rhizopus, rhizomucor, mucor. Dimorphic Fungi bl t hi t l Presenter Vikas Naik Moderator Aditya Gupta Deepak Gupta Introduction Fungi are saphrophytes Yeast candida, cryptococcus, trichosporon Filamentous rhizopus, rhizomucor, mucor Dimorphic Fungi bl t hi t

More information

Elements for a Public Summary. [Product Name] 40 mg/ml oral suspension. VI.2.1 Overview of disease epidemiology

Elements for a Public Summary. [Product Name] 40 mg/ml oral suspension. VI.2.1 Overview of disease epidemiology VI.2 Elements for a Public Summary [Product Name] 40 mg/ml oral suspension VI.2.1 Overview of disease epidemiology Fungi (yeasts) are small organisms that feed by breaking down tissue. In humans, fungi

More information

Challenges and controversies of Invasive fungal Infections

Challenges and controversies of Invasive fungal Infections Challenges and controversies of Invasive fungal Infections Mona Al-Dabbagh, MD, MHSc Assistant Professor of Pediatrics, COM-KSAU-HS Consultant Pediatric Infectious Diseases and Transplant Infectious Diseases

More information